Highly immunogenic variant of attenuated vaccinia virus


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

The LIVPΔ6 strain of vaccinia virus (VACV) was created by genetic engineering on the basis of previously obtained attenuated 1421ABJCN strain by target deletion of the A35R gene encoding an inhibitor of antigen presentation by the major histocompatibility complex class II. 1421ABJCN is the LIVP strain of VACV with five inactivated virulence genes encoding hemagglutinin (A56R), γ-interferon-binding protein (B8R), thymidine kinase (J2R), complement-binding protein (C3L), and Bcl2-like inhibitor of apoptosis (N1L). The highly immunogenic LIVPΔ6 strain could be an efficient fourth-generation attenuated vaccine against smallpox and other orthopoxvirus infections.

Sobre autores

S. Yakubitskyi

Vector State Research Center of Virology and Biotechnology

Autor responsável pela correspondência
Email: snshchel@vector.nsc.ru
Rússia, Koltsovo, Novosibirsk oblast, 633159

I. Kolosova

Vector State Research Center of Virology and Biotechnology

Email: snshchel@vector.nsc.ru
Rússia, Koltsovo, Novosibirsk oblast, 633159

R. Maksyutov

Vector State Research Center of Virology and Biotechnology

Email: snshchel@vector.nsc.ru
Rússia, Koltsovo, Novosibirsk oblast, 633159

S. Shchelkunov

Vector State Research Center of Virology and Biotechnology

Email: snshchel@vector.nsc.ru
Rússia, Koltsovo, Novosibirsk oblast, 633159

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Pleiades Publishing, Ltd., 2016